Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Life Sciences research
Life Sciences
UK residential REITs: the start of a journey
By
Mike Foster
30 Nov 2017
Redx Pharma
Life Sciences
Streamlined and clean
By
Dr Martin Hall
13 Nov 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Alliance Pharma Plc
Life Sciences
Kelo-cote building international sales
By
Dr Martin Hall
17 Oct 2017
Avacta Group plc
Life Sciences
R&D accelerated to advance assets
By
Dr Martin Hall
16 Oct 2017
Tissue Regenix
Life Sciences
Dual revenue stream growth
By
Dr Dorothea Hill
11 Oct 2017
Allergy Therapeutics plc
Life Sciences
Continuing to gain market share
By
Dr Martin Hall
10 Oct 2017
ValiRx
Life Sciences
Progressing all the pipeline
By
Dr Dorothea Hill
06 Oct 2017
Scancell Holdings
Life Sciences
Preparing for next clinical studies
By
Dr Martin Hall
03 Oct 2017
Advanced Oncotherapy
Life Sciences
Technology advances & stronger balance sheet
By
Dr Martin Hall
02 Oct 2017
ValiRx
Life Sciences
Positive early data from VAL401
By
Dr Dorothea Hill
28 Sep 2017
Collagen Solutions Plc
Life Sciences
Engineering towards CE Mark
By
Dr Martin Hall
21 Sep 2017
Prev
1
...
12
13
14
15
16
17
Next
